Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2008 Nov 25;4(1):103–115. doi: 10.1007/s11481-008-9139-x

Figure 2. Deletion mutation analysis of the −848/−674 region of OTK18 5’-proximal promoter region.

Figure 2

The cell line was transfected with a series of pGL3 constructs with pTK-RL, infected with pseudotyped YU2 (2,500 cpm/ml, black columns), and subjected to dual-luciferase assays. * and # denote p<0.05 vs. uninfected control of the same pGL3 construct-transfected group or −884/+1 group (white column) as determined by ANOVA and Newman Keuls post-hoc, respectively.